Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group. (6th February 2019)

• Record Type: Journal Article
• Authors: Wilcox, Mark; Al-Obeid, Suleiman; Gales, Ana; Kozlov, Roman; Martínez-Orozco, José A; Rossi, Flavia; Sidorenko, Sergey; Blondeau, Joseph
• Is Part Of: Future microbiology. Volume 14:Number 4(2019)
• Page Start: 345
• Page End: 352
• Publication Date: 2019-02-06
• Subjects: CA-MRSA -- HA-MRSA -- minimum inhibitory concentration -- susceptibility -- vancomycin; Microbiology -- Research -- Periodicals; 616.9041
• DOI: 10.2217/fmb-2018-0346
• Languages: English
• ISSNs: 1746-0913

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) remains an important cause of serious infection, for which vancomycin is often recommended as the first-choice antibiotic treatment. Appropriate vancomycin prescribing requires accurate measurement of minimum inhibitory concentrations (MICs) to avoid treatment failure, and yet determination can be challenging due to methodological difficulties associated with susceptibility testing. An International Working Group of infectious disease specialists and clinical/medical microbiologists reached a consensus that empirical MRSA infection therapies should be chosen regardless of the suspected origin of the infecting strain (e.g., community or hospital) due to the complex intermingling epidemiology of MRSA clones in these settings. Also, if an elevated vancomycin MIC in the susceptible range is obtained in routine testing, an alternative second method should be used for confirmation and to aid antibiotic therapy recommendations. There is no absolutely dependable method for the accurate determination of vancomycin MIC, but broth microdilution appears to be the most reliable.